ID: ALA4568157

Max Phase: Preclinical

Molecular Formula: C20H31NO3

Molecular Weight: 333.47

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCCCCCCC(C)(O)/C=C/CNC(=O)OCc1ccccc1

Standard InChI:  InChI=1S/C20H31NO3/c1-3-4-5-6-10-14-20(2,23)15-11-16-21-19(22)24-17-18-12-8-7-9-13-18/h7-9,11-13,15,23H,3-6,10,14,16-17H2,1-2H3,(H,21,22)/b15-11+

Standard InChI Key:  UIUJODROLDVQEQ-RVDMUPIBSA-N

Associated Targets(non-human)

Ghrelin O-acyltransferase 37 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 333.47Molecular Weight (Monoisotopic): 333.2304AlogP: 4.58#Rotatable Bonds: 11
Polar Surface Area: 58.56Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 4.82CX LogD: 4.82
Aromatic Rings: 1Heavy Atoms: 24QED Weighted: 0.46Np Likeness Score: 0.71

References

1.  (2012)  Small molecule inhibitors of ghrelin O-acyltransferase, 

Source